Skip to main content
Signal8

Full Access with Signal8 Pro, $49/mo billed annually.

Onconetix, Inc. (ONCO) Form S-1/A — Aug 31, 2026

$ONCOForm S-1/AFiled Aug 31, 2026, 4:05 PM ET0001213900-26-095703Original filing

Onconetix filed this S-1/A to register the resale by Seven Knots LLC of up to 100,000,000 shares of common stock issuable upon conversion of Series F preferred stock from a July 2026 PIPE that closed at an aggregate purchase price of $30,249,600. If all registered shares were issued they would equal 2,282% of the company's 4,380,522 shares outstanding, and Onconetix will receive no proceeds from any sales.

Key figures

Net Income
-$14.0 million net loss FY2025 (-$58.7 million FY2024)
Cash Position
approximately $5.1 million as of August 28, 2026 ($5.9 million at June 30, 2026)
Shares Offered
100000000
Last Sale Price
0.612
Working Capital
approximately $3.6 million
Dilution Percent
2,282% of shares outstanding if all registered shares are issued
Reverse Splits2026
1:5 (March 25, 2026) and 1:10 (May 21, 2026)
Series FFloor Price
0.19534
Accumulated Deficit
approximately $138.3 million
Default Dividend Rate
15% per annum during trigger events
Net Loss Six Months2026
-$7,082,178
July2026 ELOCCommitment
$750,000,000 (capped at 789,426 shares pending stockholder approval)
Series FConversion Price
0.9767
Shares Outstanding After
104380522
Shares Outstanding Prior
4380522
Nasdaq Exchange Cap Shares
789426
Series FPipe Purchase Price
$30,249,600 (including $249,600 cash and cancellation of a $30,000,000 commitment fee)
Six Month Operating Cash Use
approximately $4.0 million
Keystone Eloc Gross Proceeds
approximately $11.7 million through August 28, 2026
Company Optional Redemption Price
125% of greater of conversion amount or conversion rate times highest closing price

Price after filing

1 day: +4.1%7 days: +62.7%30 days: +30.8%

Close on the filing date to close N calendar days later (from $0.63). Historical, not a forecast.

AI analysis

Red flags9 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.